Jean-Yves Couraud

Title: Jean-Yves Couraud: Innovator in Antibody Research

Introduction

Jean-Yves Couraud is a prominent inventor based in Paris, France. He is known for his significant contributions to the field of antibody research, particularly in relation to cancer therapies. His work has implications for the treatment and diagnosis of various cancers, including glioblastoma.

Latest Patents

Jean-Yves Couraud holds a patent titled "Antibody against the endothelin receptor subtype A, and uses thereof." This invention pertains to antibodies against the endothelin receptor subtype A, specifically monoclonal antibodies, fragments, or derivatives thereof. The patent also covers the therapeutic or diagnostic applications of this antibody, highlighting its potential as a research tool in cancer treatment.

Career Highlights

Throughout his career, Couraud has worked with notable institutions such as the Commissariat à l'Énergie Atomique et aux Énergies Alternatives and Université Paris Cité. His research has focused on developing innovative solutions to combat cancer, showcasing his dedication to advancing medical science.

Collaborations

Jean-Yves Couraud has collaborated with esteemed colleagues, including Didier Boquet and Amaury Herbet. These partnerships have contributed to the success of his research endeavors and the development of his patented technologies.

Conclusion

Jean-Yves Couraud's work in antibody research exemplifies the impact of innovation in the medical field. His contributions continue to pave the way for advancements in cancer treatment and diagnosis.